0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      4CPS-229 Pharmaceutical interventions in the management of parenteral nutrition in critically ill patients

      meeting-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Currently, the functions of the clinical pharmacist in relation to parenteral nutrition (PN) are based on the preparation of these formulas and checking that the composition is adapted to the nutritional requirements and the clinical situation of the patient. The pharmacist can collaborate with the intensive care unit (ICU) physicians in the optimisation of nutritional support in critical patients.

          Purpose

          Description and analysis of pharmaceutical interventions (PIs) concerning PN in critical patients and the establishment of the degree of acceptance by physicians who belong to the ICU in a tertiary hospital.

          Material and methods

          A prospective study was conducted (July to September 2017). Variables included: demographics, indication of PN and type of PI. Data were obtained from medical and pharmaceutical nutrition records.

          Results

          Four hundred and fifty-one PN prescriptions were recorded for 33 patients (30% were females; mean age was 61, range 19–70). The average duration of treatment with PN was 18 days (1–44). Seventy-six interventions were recorded (2.3 PIs/patient). 5.3% were made at the beginning of the prescription, 92.1% were follow-up interventions and 2.6% were made at the end of the PN therapy.

          Distribution of PIs according to indication: postoperative complications (36.8%); colorectal surgery (18.4%); upper gastrointestinal tract surgery (17.1%); pancreatitis (13.2%); critically ill patients with a contraindication to enteral feeding (13.2%) and liver diseases (1.3%).

          Regarding the kind of PI, 7.9% of them were made to recommend stopping PN administration or putting off the end, 59.2% were to propose a change in macronutrient composition according to requirements; 6.6% were adjustment in hours of infusion/day in cholestasis, 7.9% were modifications in the amount of electrolytes administered parenterally, 15.8% were a request for laboratory markers of nutritional status and 2. 6% were about the insulin in the PN monitoring.

          86.8% of PIs were accepted by physicians.

          Conclusion

          More than two PIs were performed per patient, mostly during the treatment follow-up and in patients with heterogeneous indications of PN. Most of the PIs were due to the need for adjusting the composition of the macronutrients to the nutritional requirements and the patient’s clinical situation. The acceptance rate of PIs was highly significant, which demonstrates that ICU physicians take into account these recommendations.

          No conflict of interest

          Related collections

          Author and article information

          Journal
          Eur J Hosp Pharm
          Eur J Hosp Pharm
          ejhpharm
          ejhpharm
          European Journal of Hospital Pharmacy
          BMJ Group (BMA House, Tavistock Square, London, WC1H 9JR )
          2047-9956
          2047-9964
          2018
          2 March 2018
          : 25
          : Suppl 1 , Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden
          : A148
          Affiliations
          Hospital Virgen de la Victoria, Hospital Pharmacy, Málaga, Spain
          Article
          PMC7535221 PMC7535221 7535221 ejhpharm-2018-eahpconf.319
          10.1136/ejhpharm-2018-eahpconf.319
          7535221
          5e9247c2-b7ec-4a66-9dcd-e365d2e4e487
          © 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
          History
          Categories
          Section 4: Clinical pharmacy services

          Comments

          Comment on this article